Vinik, Aaron I.

2020

Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.. Endocrinology, diabetes & metabolism. e00101.

Full Text via DOI: 10.1002/edm2.101 PMID: 31922028

2019

Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment. FRONTIERS IN ENDOCRINOLOGY. 10.

Full Text via DOI: 10.3389/fendo.2019.00311 PMID: 31156558

2019

Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. ONCOLOGIST. 24:463-474.

Full Text via DOI: 10.1634/theoncologist.2018-0217 PMID: 30355775

2019

Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients. PANCREAS. 455-456.

2019

Electrochemical skin conductance to measure sudomotor function: the importance of not misinterpreting the evidence. CLINICAL AUTONOMIC RESEARCH. 13-15.

Full Text via DOI: 10.1007/s10286-018-0562-7 PMID: 30191428

2019

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial. PATIENT-RELATED OUTCOME MEASURES. 10:335-343.

Full Text via DOI: 10.2147/PROM.S219982 PMID: 31754316

2019

Development and Validation of the Norfolk Quality of Life Fatigue Tool (QOL-F): A New Measure of Perception of Fatigue.. Journal of the American Medical Directors Association.

Full Text via DOI: 10.1016/j.jamda.2019.10.021 PMID: 31859222

2019

Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors. ONCOLOGIST. 24:1331-1339.

Full Text via DOI: 10.1634/theoncologist.2018-0798 PMID: 31015313

2019

Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed-ratio combination in North American patients compared with the rest of world. BMJ OPEN DIABETES RESEARCH & CARE. 7.

Full Text via DOI: 10.1136/bmjdrc-2018-000581 PMID: 31114694

2018

Topiramate as a disease modifying therapy for cryptogenic sensory peripheral neuropathy: Design and analysis plan. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 326-326.

2018

The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus. CURRENT MEDICAL RESEARCH AND OPINION. 34:2015-2022.

Full Text via DOI: 10.1080/03007995.2018.1509304 PMID: 30084288

2018

BIOCHEMICAL RESPONSES IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH NEUROENDOCRINE TUMORS: POOLED ANALYSIS OF TWO PHASE 3 TRIALS. ENDOCRINE PRACTICE. 24:948-962.

Full Text via DOI: 10.4158/EP-2018-0296 PMID: 30084687

2018

Low blood pressure levels for fall injuries in older adults: the Health, Aging and Body Composition Study. EUROPEAN JOURNAL OF AGEING. 15:321-330.

Full Text via DOI: 10.1007/s10433-017-0449-9 PMID: 30310378

2018

Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events. FRONTIERS IN NEUROSCIENCE.

Full Text via DOI: 10.3389/fnins.2018.00591 PMID: 30210276

2018

Diagnostic accuracy of neuropathy tests in obese population remains elusive. CLINICAL NEUROPHYSIOLOGY. 1502-1503.

Full Text via DOI: 10.1016/j.clinph.2018.03.039 PMID: 29699877

2018

Pulse Wave Analysis of HbA1C Categorized Prediabetes, Type 2 Diabetes and Normo-Glycemic Populations: A Pilot Study. MEDICINE & SCIENCE IN SPORTS & EXERCISE. 536-536.

2018

5-Hydroxyindoleacetic Acid (5-HIAA) and Chromogranin A (CgA) as Biomarkers Secreted by Neuroendocrine Tumors (NETs): A Pooled Analysis of the ELECT and CLARINET Studies. PANCREAS. 339-339.

2018

Change in Patient-Reported Symptom Control in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot. PANCREAS. 358-358.

2018

Elevated Levels of 5-HIAA and CgA in Patients With Pancreatic Neuroendocrine Tumors (PanNETs): Analyses From the CLARINET Study. PANCREAS. 350-351.

2018

LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAIVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY. ENDOCRINE PRACTICE. 24:243-255.

Full Text via DOI: 10.4158/EP172000.OR PMID: 29547049

2018

Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors (NETs) Previously Responsive to Octreotide: Subanalysis of Patient-Reported Symptoms From the Phase 3 ELECT Study. PANCREAS. 352-352.

2018

Safety and Tolerability of Lanreotide Autogel/Depot in Patients With Neuroendocrine Tumors: Pooled Analysis of Clinical Studies. PANCREAS. 351-351.

2018

Somatostatin Analog Usage in Neuroendocrine Tumors: A Retrospective Database Analysis. PANCREAS. 344-345.

2018

Supervised Balance Training and Wii Fit-Based Exercises Lower Falls Risk in Older Adults With Type 2 Diabetes. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 19.

Full Text via DOI: 10.1016/j.jamda.2017.11.004 PMID: 29289541

2018

A Comparison of Retrospective Database Analysis with Chart Review in Patients Receiving Somatostatin Analog (SSA) in Neuroendocrine Tumors (NETs). NEUROENDOCRINOLOGY. 197-197.

2018

Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments. JOURNAL OF DIABETES RESEARCH.

Full Text via DOI: 10.1155/2018/5378439 PMID: 30648115

2018

Improved Patient Outcomes by Normalizing Sympathovagal Balance: Differentiating Syncope-Precise Subtype Differentiation Leads to Improved Outcomes. CARDIOLOGY RESEARCH AND PRACTICE.

Full Text via DOI: 10.1155/2018/9532141 PMID: 29862071

2018

Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study. ONCOLOGIST. 23:16-24.

Full Text via DOI: 10.1634/theoncologist.2017-0284 PMID: 29038234

2017

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION. ENDOCRINE PRACTICE. 23:1472-1478.

Full Text via DOI: 10.4158/EP-2017-0053 PMID: 29320641

2017

Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 102:4343-4410.

Full Text via DOI: 10.1210/jc.2017-01922 PMID: 29126250

2017

Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study. PAIN MEDICINE. 18:2198-2207.

Full Text via DOI: 10.1093/pm/pnw342 PMID: 28371941

2017

Change in Patient-Reported Symptom Control in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot. AMERICAN JOURNAL OF GASTROENTEROLOGY. S652-S653.

2017

Relationship between sensorimotor peripheral nerve function and indicators of cardiovascular autonomic function in older adults from the Health, Aging and Body Composition Study. EXPERIMENTAL GERONTOLOGY. 96:38-45.

Full Text via DOI: 10.1016/j.exger.2017.04.007 PMID: 28442382

2017

AGING, DIABETES, AND FALLS. ENDOCRINE PRACTICE. 1117-1139.

Full Text via DOI: 10.4158/EP171794.RA PMID: 28704101

2017

SARCOPENIA: AN ENDOCRINE DISORDER?. ENDOCRINE PRACTICE. 1140-1149.

Full Text via DOI: 10.4158/EP171795.RA PMID: 28704095

2017

Untitled. ENDOCRINE PRACTICE. 1156-1158.

2017

PRECISION MEDICINE IN ADRENAL DISORDERS: THE NEXT GENERATION. ENDOCRINE PRACTICE. 672-679.

Full Text via DOI: 10.4158/EP161716.RA PMID: 28332880

2017

Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy. FRONTIERS IN ENDOCRINOLOGY.

Full Text via DOI: 10.3389/fendo.2017.00089 PMID: 28512447

2017

Clinical measures in transthyretin familial amyloid polyneuropathy. MUSCLE & NERVE. 55:323-332.

Full Text via DOI: 10.1002/mus.25257 PMID: 27422379

2017

Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy. MUSCLE & NERVE. 55:366-372.

Full Text via DOI: 10.1002/mus.25264 PMID: 27447116

2017

Efficacy of Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor Patients: Follow-up Analysis of the ELECT Prospective, Randomized, Double-blind and Open-label Phases. PANCREAS. 433-434.

2017

Long-Term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients With Carcinoid Syndrome (CS): The ELECT Long-Term Open-label Extension. PANCREAS. 437-437.

2017

SUSTAINED SYMPTOM CONTROL WITH LANREOTIDE DEPOT IN CARCINOID SYNDROME (CS) IN NEUROENDOCRINE TUMOR PATIENTS: FOLLOW-UP ANALYSIS OF THE ELECT PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND OPEN-LABEL PHASES.. ONCOLOGY NURSING FORUM.

2017

A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes. JOURNAL OF DIABETES RESEARCH.

Full Text via DOI: 10.1155/2017/1467213 PMID: 29250555

2017

SUMMARY: GLIDING THROUGH THE GOLDEN YEARS GRACEFULLY.. ENDOCRINE PRACTICE. 1107-1109.

Full Text via DOI: 10.4158/EP171797.LT PMID: 29028363

2017

Safety and Tolerability of Lanreotide Autogel/Depot (LAN) in Patients (pts) with Neuroendocrine Tumours (NETs): Pooled Analysis of Clinical Studies. NEUROENDOCRINOLOGY. 206-206.

2017

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. ANNALS OF ONCOLOGY. 28:339-343.

Full Text via DOI: 10.1093/annonc/mdw561 PMID: 27836885

2017

Untitled. ENDOCRINE PRACTICE. 1156-1158.

Full Text via DOI: 10.4158/1934-2403-23.9.1156 PMID: 28920750

2016

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC NEUROLOGY. 16.

Full Text via DOI: 10.1186/s12883-016-0752-7 PMID: 27919222

2016

Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial. TARGETED ONCOLOGY. 11:815-824.

Full Text via DOI: 10.1007/s11523-016-0462-5 PMID: 27924459

2016

Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. S468-S468.

2016

Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study. ARTHRITIS & RHEUMATOLOGY.

2016

Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. S457-S458.

2016

EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. ENDOCRINE PRACTICE. 22:1068-1080.

Full Text via DOI: 10.4158/EP151172.OR PMID: 27214300

2016

Mobility-Related Consequences of Reduced Lower-Extremity Peripheral Nerve Function with Age: A Systematic Review. AGING AND DISEASE. 466-478.

Full Text via DOI: 10.14336/AD.2015.1127 PMID: 27493833

2016

The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus. FRONTIERS IN ENDOCRINOLOGY.

Full Text via DOI: 10.3389/fendo.2016.00055 PMID: 27375553

2016

Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. DIABETES TECHNOLOGY & THERAPEUTICS. 18:391-398.

Full Text via DOI: 10.1089/dia.2015.0396 PMID: 27057778

2016

Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLOS ONE. 11.

Full Text via DOI: 10.1371/journal.pone.0154211 PMID: 27137224

2016

Diabetic Sensory and Motor Neuropathy. NEW ENGLAND JOURNAL OF MEDICINE. 374:1455-1464.

Full Text via DOI: 10.1056/NEJMcp1503948 PMID: 27074068

2016

Efficacy and Safety of Lanreotide Depot vs Placebo in Patients With Neuroendocrine Tumor and a History of Carcinoid Syndrome and Prior Octreotide Therapy. PANCREAS. 475-475.

2016

Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 30:350-356.

Full Text via DOI: 10.1016/j.jdiacomp.2015.10.018 PMID: 26651260

2016

SAFETY AND EFFICACY OF LANREOTIDE DEPOT VS PLACEBO IN NEUROENDOCRINE TUMOR PATIENTS WITH A HISTORY OF CARCINOID SYNDROME AND PRIOR OCTREOTIDE THERAPY.. ONCOLOGY NURSING FORUM. 133-134.

2016

Clinical Presentation and Diagnosis of Neuroendocrine Tumors. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 30:21-+.

Full Text via DOI: 10.1016/j.hoc.2015.08.006 PMID: 26614367

2016

Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy. CONTROVERSIES IN DIABETIC NEUROPATHY. 235-285.

Full Text via DOI: 10.1016/bs.irn.2016.03.010 PMID: 27133153

2016

Delay between Onset of Symptoms and Seeking Physician Intervention Increases Risk of Diabetic Foot Complications: Results of a Cross-Sectional Population-Based Survey. JOURNAL OF DIABETES RESEARCH.

Full Text via DOI: 10.1155/2016/1567405 PMID: 28018920

2016

Epidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey. JOURNAL OF DIABETES RESEARCH.

Full Text via DOI: 10.1155/2016/5439521 PMID: 27019852

2016

Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status. DIABETES CARE. 39:801-807.

Full Text via DOI: 10.2337/dc16-0081 PMID: 26965720

2016

Sensorimotor Peripheral Nerve Function and the Longitudinal Relationship With Endurance Walking in the Health, Aging and Body Composition Study. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION. 97:45-52.

Full Text via DOI: 10.1016/j.apmr.2015.08.423 PMID: 26343170

2016

Sunitinib (SU) in Patients with Advanced, Progressive Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results from a Phase III Randomized Study Including Adjustment for Crossover. NEUROENDOCRINOLOGY. 84-84.

2015

Safety and Efficacy of Lanreotide Depot Versus Placebo in Neuroendocrine Tumor Patients With a History of Carcinoid Syndrome and Prior Octreotide Therapy. AMERICAN JOURNAL OF GASTROENTEROLOGY. S1007-S1007.

2015

Capsaicin 8% patch repeat treatment versus standard of care in painful diabetic peripheral neuropathy: a randomised, open-label, 52-week study. DIABETOLOGIA. S514-S515.

2015

Capsaicin 8% patch versus standard of care in painful diabetic peripheral neuropathy: efficacy of seven consecutive treatments over 52 weeks versus. DIABETOLOGIA. S515-S515.

2015

Capsaicin 8% patch versus standard of care in painful diabetic peripheral neuropathy: safety of seven consecutive treatments over 52 weeks. DIABETOLOGIA. S515-S516.

2015

Efficacy, quality of life and treatment satisfaction with capsaicin 8% patch versus standard of care in painful diabetic peripheral neuropathy. DIABETOLOGIA. S514-S514.

2015

Detection of undisclosed neuropathy and assessment of its impact on quality of life: a survey in 25,000 Romanian patients with diabetes. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 29:644-649.

Full Text via DOI: 10.1016/j.jdiacomp.2015.04.001 PMID: 25922309

2015

Early Detection of Sporadic Pancreatic Cancer Summative Review. PANCREAS. 693-712.

Full Text via DOI: 10.1097/MPA.0000000000000368 PMID: 25931254

2015

Nonblood/Urine Biomarker of Progression of Kidney Disease in Diabetes Mellitus. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1114-1116.

Full Text via DOI: 10.2215/CJN.05640515 PMID: 26092829

2015

Role of Peroxynitrite in the Development of Diabetic Peripheral Neuropathy. DIABETES CARE. e100-e101.

Full Text via DOI: 10.2337/dc14-2918 PMID: 26106228

2015

The new age of sudomotor function testing: a sensitive and specific biomarker for diagnosis, estimation of severity, monitoring progression, and regression in response to intervention. FRONTIERS IN ENDOCRINOLOGY.

Full Text via DOI: 10.3389/fendo.2015.00094 PMID: 26124748

2015

DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF HEPATOCYTE GROWTH FACTOR GENE THERAPY IN PAINFUL DIABETIC NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 94-94.

2015

Pathways in the Diagnosis and Management of Diabetic Polyneuropathy. CURRENT DIABETES REPORTS. 15.

Full Text via DOI: 10.1007/s11892-015-0609-2 PMID: 25899758

2015

AACE/ACE DISEASE STATE CLINICAL REVIEW: DIAGNOSIS AND MANAGEMENT OF MIDGUT CARCINOIDS. ENDOCRINE PRACTICE. 534-545.

Full Text via DOI: 10.4158/EP14464.DSC PMID: 25962092

2015

Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2:465-478.

Full Text via DOI: 10.1002/acn3.186 PMID: 26000320

2015

Sensory and Motor Peripheral Nerve Function and Longitudinal Changes in Quadriceps Strength. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 70:464-470.

Full Text via DOI: 10.1093/gerona/glu183 PMID: 25320056

2015

CIDP variants in diabetes: measuring treatment response with a small nerve fiber test. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 29:313-317.

Full Text via DOI: 10.1016/j.jdiacomp.2014.10.012 PMID: 25466645

2015

A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy. CLINICAL DRUG INVESTIGATION. 35:95-108.

Full Text via DOI: 10.1007/s40261-014-0249-3 PMID: 25503082

2015

Falls Risk in Older Adults with Type 2 Diabetes. CLINICS IN GERIATRIC MEDICINE. 31:89-+.

Full Text via DOI: 10.1016/j.cger.2014.09.002 PMID: 25453303

2015

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN-2015. ENDOCRINE PRACTICE. 21:1-87.

Full Text via DOI: 10.4158/EP15672.GLSUPPL PMID: 25869408

2015

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN-2015-EXECUTIVE SUMMARY. ENDOCRINE PRACTICE. 21:413-437.

PMID: 27408942

2015

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus. JOURNAL OF DIABETES RESEARCH.

Full Text via DOI: 10.1155/2015/157698 PMID: 26060823

2014

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Adaptive Proof-of-Concept Phase 2 Study. DIABETES CARE. 37:3253-3261.

Full Text via DOI: 10.2337/dc14-1044 PMID: 25231896

2014

Sensory and Motor Peripheral Nerve Function and Incident Mobility Disability. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 62:2273-2279.

Full Text via DOI: 10.1111/jgs.13152 PMID: 25482096

2014

ADVANCES IN DIAGNOSIS AND TREATMENT OF PANCREATIC NEUROENDOCRINE TUMORS. ENDOCRINE PRACTICE. 1222-1230.

Full Text via DOI: 10.4158/EP14373.RA PMID: 25297671

2014

Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 28:715-722.

Full Text via DOI: 10.1016/j.jdiacomp.2014.04.007 PMID: 24929798

2014

Gender differences in impact of self-reported diabetes and neuropathy on quality of life in a large study on Romanian patients. DIABETOLOGIA. S465-S466.

2014

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy. DIABETES CARE. 37:2302-2309.

Full Text via DOI: 10.2337/dc13-2291 PMID: 24848284

2014

Acute Effect of Breathing Exercises on Heart Rate Variability in Type 2 Diabetes: A Pilot Study. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE. 20:642-648.

Full Text via DOI: 10.1089/acm.2013.0280 PMID: 24984088

2014

Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 19:104-114.

Full Text via DOI: 10.1111/jns5.12059 PMID: 24738700

2014

Prediction of Pregabalin-Mediated Pain Response by Severity of Sleep Disturbance in Patients with Painful Diabetic Neuropathy and Post-Herpetic Neuralgia. PAIN MEDICINE. 15:661-670.

Full Text via DOI: 10.1111/pme.12310 PMID: 24330406

2014

Exercising With Peripheral or Autonomic Neuropathy: What Health Care Providers and Diabetic Patients Need to Know. PHYSICIAN AND SPORTSMEDICINE. 42:15-23.

Full Text via DOI: 10.3810/psm.2014.02.2043 PMID: 24565817

2014

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results. HEART INTERNATIONAL. 9:15-21.

Full Text via DOI: 10.5301/HEART.2014.12496 PMID: 27004092

2014

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. HEART INTERNATIONAL. 9:7-14.

Full Text via DOI: 10.5301/HEART.2014.12495 PMID: 27004091

2014

ELECT: A Phase 3 Study of Efficacy and Safety of Lanreotide Autogel (LAN) Treatment for Carcinoid Syndrome (CS) in Patients (Pts) with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). NEUROENDOCRINOLOGY. 271-271.

2014

Epidemiology of polyneuropathy in diabetes and prediabetes.. Handbook of clinical neurology. 3-22.

Full Text via DOI: 10.1016/B978-0-444-53480-4.00001-1 PMID: 25410210

2014

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 77-87.

Full Text via DOI: 10.1111/jns5.12072 PMID: 24934510

2014

The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. FRONTIERS IN ENDOCRINOLOGY.

Full Text via DOI: 10.3389/fendo.2014.00047 PMID: 24778627

2013

Diabetic Neuropathy. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 42:747-+.

Full Text via DOI: 10.1016/j.ecl.2013.06.001 PMID: 24286949

2013

Sudoscan, a Noninvasive Tool for Detecting Diabetic Small Fiber Neuropathy and Autonomic Dysfunction. DIABETES TECHNOLOGY & THERAPEUTICS. 15:948-953.

Full Text via DOI: 10.1089/dia.2013.0129 PMID: 23889506

2013

Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 6:396-411.

Full Text via DOI: 10.1177/1756283X13493878 PMID: 24003340

2013

Neurovascular Function and Sudorimetry in Health and Disease. CURRENT DIABETES REPORTS. 13:517-532.

Full Text via DOI: 10.1007/s11892-013-0392-x PMID: 23681491

2013

Exercise improves cardiac autonomic function in obesity and diabetes. METABOLISM-CLINICAL AND EXPERIMENTAL. 609-621.

Full Text via DOI: 10.1016/j.metabol.2012.09.005 PMID: 23084034

2013

Relationship Between Pain Relief and Improvements in Patient Function/Quality of Life in Patients With Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Treated With Pregabalin. CLINICAL THERAPEUTICS. 35:612-623.

Full Text via DOI: 10.1016/j.clinthera.2013.03.008 PMID: 23541708

2013

A Single Fasting Plasma 5-HIAA Value Correlates With 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs). PANCREAS. 42:405-410.

Full Text via DOI: 10.1097/MPA.0b013e318271c0d5 PMID: 23160483

2013

A Single Fasting Plasma 5-HIAA Value Correlates with 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs). PANCREAS. 374-374.

2013

Reproducibility of peroneal motor nerve conduction measurement in older adults. CLINICAL NEUROPHYSIOLOGY. 124:603-609.

Full Text via DOI: 10.1016/j.clinph.2012.07.027 PMID: 23022036

2013

Role of prostaglandin D-2 and the autonomic nervous system in niacin-induced flushing. JOURNAL OF DIABETES. 5:59-67.

Full Text via DOI: 10.1111/j.1753-0407.2012.00216.x PMID: 22727040

2013

Sunitinib for the Treatment of Metastatic Paraganglioma and Vasoactive Intestinal Polypeptide-Producing Tumor (VIPoma). PANCREAS. 42:348-352.

Full Text via DOI: 10.1097/MPA.0b013e31825c53fa PMID: 23407483

2013

A Medicinal Food Provides Food for Thought in Managing Diabetic Neuropathy. AMERICAN JOURNAL OF MEDICINE. 95-96.

Full Text via DOI: 10.1016/j.amjmed.2012.08.008 PMID: 23331432

2013

VITAMIN B-12 AND PERIPHERAL NERVE FUNCTION IN ELDERLY ADULTS: "FUNCTIONAL" B-12 DEFICIENCY AS A CONFOUNDING VARIABLE RESPONSE. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 312-313.

2013

Contact Heat-Evoked Potential Stimulation for the Evaluation of Small Nerve Fiber Function. DIABETES TECHNOLOGY & THERAPEUTICS. 15:150-157.

Full Text via DOI: 10.1089/dia.2012.0202 PMID: 23298343

2013

Diabetic autonomic neuropathy.. Handbook of clinical neurology. 279-94.

Full Text via DOI: 10.1016/B978-0-444-53491-0.00022-5 PMID: 24095132

2013

Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. JOURNAL OF DIABETES INVESTIGATION. 4-18.

Full Text via DOI: 10.1111/jdi.12042

2013

Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY. 57-78.

Full Text via DOI: 10.2147/DMSO.S24825 PMID: 23467255

2013

VITAMIN B-12 AND PERIPHERAL NERVE FUNCTION IN ELDERLY ADULTS: "FUNCTIONAL" B-12 DEFICIENCY AS A CONFOUNDING VARIABLE RESPONSE. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 312-313.

Full Text via DOI: 10.1111/jgs.12089 PMID: 23405939

2012

"Brittleness" in Diabetes: Easier Spoken than Broken. DIABETES TECHNOLOGY & THERAPEUTICS. 835-848.

Full Text via DOI: 10.1089/dia.2012.0058 PMID: 22731792

2012

Relationship Between Vitamin B12 and Sensory and Motor Peripheral Nerve Function in Older Adults. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 60:1057-1063.

Full Text via DOI: 10.1111/j.1532-5415.2012.03998.x PMID: 22690982

2012

Vitamin B12 and Neurological Function: Is There a Threshold Level?. NEUROLOGY.

2012

Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET). PANCREAS. 350-350.

2012

Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation. EXPERIMENTAL DIABETES RESEARCH.

Full Text via DOI: 10.1155/2012/878760 PMID: 22110481

2012

EFFECT OF BROMOCRIPTINE-QR ON GLYCEMIC CONTROL IN SUBJECTS WITH UNCONTROLLED HYPERGLYCEMIA ON ONE OR TWO ORAL ANTI-DIABETES AGENTS. ENDOCRINE PRACTICE. 18:931-943.

Full Text via DOI: 10.4158/EP12187.OR PMID: 23186965

2012

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 1.

Full Text via DOI: 10.1161/JAHA.112.002279 PMID: 23316290

2012

Grand challenges in diabetes.. FRONTIERS IN ENDOCRINOLOGY. 37.

Full Text via DOI: 10.3389/fendo.2012.00037 PMID: 22649418

2012

Relation between risk of falling and postural sway complexity in diabetes. GAIT & POSTURE. 35:662-668.

Full Text via DOI: 10.1016/j.gaitpost.2011.12.021 PMID: 22269128

2012

The conductor of the autonomic orchestra.. FRONTIERS IN ENDOCRINOLOGY. 71.

Full Text via DOI: 10.3389/fendo.2012.00071 PMID: 22737143

2011

Neuropathy in prediabetes: does the clock start ticking early?. NATURE REVIEWS ENDOCRINOLOGY. 682-690.

Full Text via DOI: 10.1038/nrendo.2011.113 PMID: 21750507

2011

Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period. PANCREAS. 40:987-994.

Full Text via DOI: 10.1097/MPA.0b013e31821f66b4 PMID: 21697761

2011

Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. DIABETES-METABOLISM RESEARCH AND REVIEWS. 27:629-638.

Full Text via DOI: 10.1002/dmrr.1225 PMID: 21695762

2011

Validation of Neurokinin A Assays in the United States and Europe. PANCREAS. 40:1000-1005.

Full Text via DOI: 10.1097/MPA.0b013e318232b6a2 PMID: 21926539

2011

DISTORTED LANGERHANS CELLS IN DIABETIC PERIPHERAL NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. S109-S109.

2011

Efficacy and Safety of Antioxidant Treatment With alpha-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy The NATHAN 1 trial. DIABETES CARE. 34:2054-2060.

Full Text via DOI: 10.2337/dc11-0503 PMID: 21775755

2011

INTRAEPIDERMAL NERVE FIBER DENSITY (IENFD) PERFORMANCE IN A MULTICENTER DIABETIC NEUROPATHY CLINICAL TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. S110-S111.

2011

INTRAEPIDERMAL NERVE FIBER DENSITY RELATIONSHIP TO NEUROLOGIC AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH V30M TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. S111-S111.

2011

SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. S110-S110.

2011

VALIDATION OF NORFOLK QOL-DN AS A MEASURE OF QOL IN PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. S144-S144.

2011

Loss of RAGE Defense: A Cause of Charcot Neuroarthropathy?. DIABETES CARE. 34:1617-1621.

Full Text via DOI: 10.2337/dc10-2315 PMID: 21593297

2011

Autonomic imbalance: prophet of doom or scope for hope?. DIABETIC MEDICINE. 643-651.

Full Text via DOI: 10.1111/j.1464-5491.2010.03184.x PMID: 21569084

2011

Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET). JOURNAL OF CLINICAL ONCOLOGY.

2011

Beyond the Monofilament for the Insensate Diabetic Foot A systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes. DIABETES CARE. 1041-1046.

Full Text via DOI: 10.2337/dc10-1666 PMID: 21447666

2011

The Question Is, My Dear Watson, Why Did the Dog Not Bark? The Joslin 50-Year Medalist Study. DIABETES CARE. 1060-1063.

Full Text via DOI: 10.2337/dc11-0146 PMID: 21447670

2011

Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 335:104-109.

Full Text via DOI: 10.1016/j.mce.2010.12.026 PMID: 21187123

2011

Gastroenteropancreatic System and Its Tumors: Part 2 Preface. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. XVII-XVIII.

Full Text via DOI: 10.1016/j.ecl.2011.01.001 PMID: 21349408

2011

Measuring the Relationship of Quality of Life and Health Status, Including Tumor Burden, Symptoms, and Biochemical Measures in Patients with Neuroendocrine Tumors. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 40:97-+.

Full Text via DOI: 10.1016/j.ecl.2010.12.008 PMID: 21349413

2011

Neuroendocrine Tumors: Current Recommendations for Diagnosis and Surgical Management. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 40:205-+.

Full Text via DOI: 10.1016/j.ecl.2010.08.004 PMID: 21349420

2011

New and Emerging syndromes due to Neuroendocrine Tumors. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 40:19-+.

Full Text via DOI: 10.1016/j.ecl.2010.12.010 PMID: 21349410

2011

Sunitinib for Treatment of Pancreatic Neuroendocrine Tumors: Patient-Reported Outcomes and Efficacy Across Patient Subgroups in a Phase III Trial. PANCREAS. 334-335.

2011

Update: Metabolic and Cardiovascular Consequences of Bariatric Surgery. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 40:81-+.

Full Text via DOI: 10.1016/j.ecl.2010.12.009 PMID: 21349412

2011

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.. NEW ENGLAND JOURNAL OF MEDICINE. 364:501-513.

2011

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN. ENDOCRINE PRACTICE. 17:1-+.

Full Text via DOI: 10.4158/EP.17.S2.1 PMID: 21474420

2011

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN: EXECUTIVE SUMMARY. ENDOCRINE PRACTICE. 17:287-302.

Full Text via DOI: 10.4158/EP.17.2.287 PMID: 21474421

2011

Discussion: The Role of Peripheral Nerve Surgery in Diabetic Limb Salvage. PLASTIC AND RECONSTRUCTIVE SURGERY. 275S-278S.

Full Text via DOI: 10.1097/PRS.0b013e3182012cfe PMID: 21200302

2011

Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Full Text via DOI: 10.1177/193229681100500326 PMID: 21722587

2011

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.. NEW ENGLAND JOURNAL OF MEDICINE. 364:501-513.

Full Text via DOI: 10.1056/NEJMoa1003825 PMID: 21306237

2010

Gastroenteropancreatic System and Its Tumors: Part 1 Preface. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. XVII-XVIII.

Full Text via DOI: 10.1016/j.ecl.2010.09.005 PMID: 21095538

2010

The Approach to the Management of the Patient with Neuropathic Pain. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 95:4802-4811.

Full Text via DOI: 10.1210/jc.2010-0892 PMID: 21051576

2010

A Prospective Trial on the Effect of Body Mass Index and Sex on Plasma Octreotide Levels in Patients Undergoing Long-Term Octreotide LAR Therapy. PANCREAS. 39:964-966.

Full Text via DOI: 10.1097/MPA.0b013e3181db01a8 PMID: 20467346

2010

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. DIABETES CARE. 2285-2293.

Full Text via DOI: 10.2337/dc10-1303 PMID: 20876709

2010

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome. PITUITARY. 13:266-286.

Full Text via DOI: 10.1007/s11102-009-0210-2 PMID: 20012914

2010

NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor. PANCREAS. 39:713-734.

Full Text via DOI: 10.1097/MPA.0b013e3181ebaffd PMID: 20664471

2010

Neuroendocrine Tumors A Critical Appraisal of Management Strategies. PANCREAS. 39:801-818.

Full Text via DOI: 10.1097/MPA.0b013e3181ea5839 PMID: 20664478

2010

The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer. PANCREAS. 39:775-783.

Full Text via DOI: 10.1097/MPA.0b013e3181ebb4f0 PMID: 20664475

2010

Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior. PANCREAS. 39:611-616.

Full Text via DOI: 10.1097/MPA.0b013e3181c68d7a PMID: 20124939

2010

Neuropathy: The Crystal Ball for Cardiovascular Disease?. DIABETES CARE. 1688-1690.

Full Text via DOI: 10.2337/dc10-0745 PMID: 20587730

2010

Patient-reported outcomes (PROs) in patients (pts) with pancreatic neuroendocrine tumors (NET) receiving sunitinib (SU) in a phase III trial. JOURNAL OF CLINICAL ONCOLOGY.

2010

Relationship between objective measures of neuropathy and quality of life in stages of severity of transthyretin familial amyloid polyneuropathy. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 138-139.

2010

A Prospective Trial on the Effect of Body Mass Index and Gender on Plasma Octreotide Levels in Patients Undergoing Long Term Therapy With Octreotide LAR. PANCREAS. 273-274.

Full Text via DOI: 10.1097/01.mpa.0000363918.63101.af

2010

Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior. PANCREAS. 279-279.

Full Text via DOI: 10.1097/01.mpa.0000363937.59530.70

2010

Relationship Between Quality of Life and Health-Related Measures Including Symptoms, Biochemical Markers And Tumor Burden. PANCREAS. 282-282.

Full Text via DOI: 10.1097/01.mpa.0000363950.68046.55

2010

Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. NEUROGASTROENTEROLOGY AND MOTILITY. 113-133.

Full Text via DOI: 10.1111/j.1365-2982.2009.01434.x PMID: 20003077

2010

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY. 3:275-280.

Full Text via DOI: 10.2147/DMSO.S12136 PMID: 21437095

2010

Barely Scratching the Surface. DIABETES CARE. 210-212.

Full Text via DOI: 10.2337/dc09-2035 PMID: 20040678

2010

Biochemical Testing for Neuroendocrine Tumors (vol 38, pg 876, 2009). PANCREAS. 117-117.

2010

Pdx-1 Regulation of the INGAP Promoter Involves Sequestration of NeuroD Into a Non-DNA-Binding Complex. PANCREAS. 39:64-70.

Full Text via DOI: 10.1097/MPA.0b013e3181baa0cc PMID: 19770784

2010

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY. 3:19-26.

Full Text via DOI: 10.2147/DMSO.S8376 PMID: 21437072

2010

Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY. 3:431-437.

Full Text via DOI: 10.2147/DMSO.S13699 PMID: 21437113

2009

Biochemical Testing for Neuroendocrine Tumors. PANCREAS. 876-889.

Full Text via DOI: 10.1097/MPA.0b013e3181bc0e77 PMID: 19855234

2009

Sensory and Motor Peripheral Nerve Function and Lower-Extremity Quadriceps Strength: The Health, Aging and Body Composition Study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 57:2004-2010.

Full Text via DOI: 10.1111/j.1532-5415.2009.02487.x PMID: 19793163

2009

Risk of microvascular events following initiation of insulin glargine or NPH insulin in type 2 diabetes in the US. DIABETOLOGIA. S453-S453.

2009

Successful Control of Intractable Hypoglycemia Using Rapamycin in an 86-Year-Old Man with a Pancreatic Insulin-Secreting Islet Cell Tumor and Metastases. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 94:3157-3162.

Full Text via DOI: 10.1210/jc.2009-0788 PMID: 19567519

2009

Surveillance of lipase and amylase levels in type 2 diabetes patients assessed during a randomized clinical study: the EGO study experience. DIABETOLOGIA. S303-S304.

2009

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 735-736.

2009

THE NEUROTOXICITY-INDUCED NEUROBLASTOMA APOPTOSIS (NINA) ASSAY PREDICTS A ROLE FOR SERUM LIPOPROTEINS IN THE DEVELOPMENT OF DIABETIC NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 83-83.

2009

A role for islet neogenesis in curing diabetes. DIABETOLOGIA. 735-738.

Full Text via DOI: 10.1007/s00125-009-1322-y PMID: 19271208

2009

RELATIONSHIP BETWEEN QUALITY OF LIFE AND HEALTH-RELATED MEASURES INCLUDING SYMPTOMS, BIOCHEMICAL MARKERS AND TUMOR BURDEN. VALUE IN HEALTH. A30-A30.

2009

Development of the Norfolk Quality of Life Tool for Assessing Patients With Neuroendocrine Tumors. PANCREAS. 38:E87-E95.

Full Text via DOI: 10.1097/MPA.0b013e31819b6441 PMID: 19276865

2009

Exercise status affects skin perfusion via prostaglandin, nitric oxide, and EDHF pathways in diabetes. MICROVASCULAR RESEARCH. 77:120-124.

Full Text via DOI: 10.1016/j.mvr.2008.11.004 PMID: 19100752

2009

The Role of Islet Neogeneis-Associated Protein (INGAP) in Pancreatic Islet Neogenesis. CURRENT PROTEIN & PEPTIDE SCIENCE. 37-45.

2008

A Break in the Brake Mechanism in Diabetes A cause of postprandial hyperglycemia. DIABETES CARE. 2410-2413.

Full Text via DOI: 10.2337/dc08-1694 PMID: 19033422

2008

An Impaired Oxidative Stress Defense Mechanism May Reduce Bone Stiffness in Diabetic Charcot Neuroarthropathy.. JOURNAL OF BONE AND MINERAL RESEARCH. S374-S374.

2008

The relationship of reduced peripheral nerve function and diabetes with physical performance in older white and black adults - The Health, Aging, and Body Composition (Health ABC) Study. DIABETES CARE. 31:1767-1772.

Full Text via DOI: 10.2337/dc08-0433 PMID: 18535192

2008

Diabetic neuropathy in older adults. CLINICS IN GERIATRIC MEDICINE. 407-+.

Full Text via DOI: 10.1016/j.cger.2008.03.011 PMID: 18672180

2008

Transplantation and beyond. DRUG DEVELOPMENT RESEARCH. 69:165-176.

Full Text via DOI: 10.1002/ddr.20242

2008

Diabetes-related complications, glycemic control, and falls in older adults. DIABETES CARE. 31:391-396.

Full Text via DOI: 10.2337/dc07-1152 PMID: 18056893

2008

Pancreatic islet immunoreactivity to the Reg protein INGAP. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 56:183-191.

Full Text via DOI: 10.1369/jhc.7A7365.2007 PMID: 17998566

2008

The reg family member INGAP is a marker of endocrine patterning in the embryonic pancreas. PANCREAS. 36:1-9.

2007

A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. DIABETES CARE. 30:896-902.

Full Text via DOI: 10.2337/dc06-1699 PMID: 17392551

2007

Adding insulin glargine versus rosiglitazone - Health-related quality-of-life impact in type 2 diabetes. DIABETES CARE. 30:795-800.

Full Text via DOI: 10.2337/dc06-1712 PMID: 17259481

2007

Autonomic function in sleep apnea patients: increased heart rate variability except during REM sleep in obese patients. SLEEP AND BREATHING. 11:53-60.

Full Text via DOI: 10.1007/s11325-006-0083-9 PMID: 17171554

2007

Bariatric surgery. CLEVELAND CLINIC JOURNAL OF MEDICINE. 237-237.

2007

Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies. PAIN. 128:169-179.

Full Text via DOI: 10.1016/j.pain.2006.09.040 PMID: 17161535

2007

Surgical decompression for diabetic sensorimotor polyneuropathy. DIABETES CARE. 421-422.

Full Text via DOI: 10.2337/dc06-2324 PMID: 17259523

2007

Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. CLINICAL THERAPEUTICS. 1236-1253.

Full Text via DOI: 10.1016/j.clinthera.2007.07.005

2007

Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs. PANCREAS. 34:103-111.

2007

Reversal of phrenic nerve palsy with topiramate. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 21:63-67.

Full Text via DOI: 10.1016/j.jdiacomp.2006.04.002 PMID: 17189876

2007

Too many notes: Up and down the scales of diabetes therapy. CLINICAL THERAPEUTICS. 1227-1235.

Full Text via DOI: 10.1016/j.clinthera.2007.07.002

2006

Diabetic nerve conduction abnormalities in the primary care setting. DIABETES TECHNOLOGY & THERAPEUTICS. 8:654-662.

2006

Neuropathies in children and adolescents with diabetes: the tip of the iceberg. PEDIATRIC DIABETES. 301-304.

2006

Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS). CLINICAL ENDOCRINOLOGY. 65:566-578.

Full Text via DOI: 10.1111/j.1365-2265.2006.02629.x PMID: 17054456

2006

Reduced peripheral nerve function is related to lower hip BMD and calcaneal QUS in older white and black adults: The health, aging, and body composition study. JOURNAL OF BONE AND MINERAL RESEARCH. 21:1803-1810.

Full Text via DOI: 10.1359/JBMR.060725 PMID: 17002569

2006

Effect of a single bout of prior moderate exercise on cutaneous perfusion in type 2 diabetes. DIABETES CARE. 29:2316-2318.

Full Text via DOI: 10.2337/dc-06-1440 PMID: 17003314

2006

Validation of serum versus plasma measurements of chromogranin A levels in patients with carcinoid tumors - Lack of correlation between absolute chromogranin A levels and symptom frequency. PANCREAS. 33:250-254.

2006

Islet neogenesis associated protein transgenic mice are resistant to hyperglycernia induced by streptozotocin. JOURNAL OF ENDOCRINOLOGY. 190:729-737.

Full Text via DOI: 10.1677/joe.1.06698 PMID: 17003274

2006

Role of plasma octreotide and chromogranin A (CGA) level in the management of neuroendocrine tumors (NET). REGULATORY PEPTIDES. 126-127.

2006

The role of PPARs in the microvascular dysfunction in diabetes. VASCULAR PHARMACOLOGY. 54-64.

Full Text via DOI: 10.1016/j.vph.2005.11.012 PMID: 16784897

2006

Diabetic peripheral neuropathy: How reliable is a homemade 1-g monofilament for screening?. JOURNAL OF FAMILY PRACTICE. 55:505-508.

2006

Pioglitazone treatment improves nitrosative stress in type 2 diabetes. DIABETES CARE. 29:869-876.

2006

Treatment of gastroparesis: a multidisciplinary clinical review. NEUROGASTROENTEROLOGY AND MOTILITY. 263-283.

Full Text via DOI: 10.1111/j.1365-2982.2006.00760.x PMID: 16553582

2006

PDX-1 can repress stimulus-induced activation of the INGAP promoter. JOURNAL OF ENDOCRINOLOGY. 188:611-621.

Full Text via DOI: 10.1677/joe.1.06108 PMID: 16522740

2006

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. DIABETES OBESITY & METABOLISM. 8:49-57.

Full Text via DOI: 10.1111/j.1463-1326.2005.00541.x PMID: 16367882

2005

The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 14:1547-1559.

Full Text via DOI: 10.1517/13543784.14.12.1547 PMID: 16307493

2005

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. PANCREAS. 31:392-400.

2005

Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy. MUSCLE & NERVE. 32:619-625.

Full Text via DOI: 10.1002/mus.20423 PMID: 16116628

2005

Change in cutaneous perfusion following 10 weeks of aerobic training in Type 2 diabetes. JOURNAL OF DIABETES AND ITS COMPLICATIONS. 19:276-283.

Full Text via DOI: 10.1016/j.jdiacomp.2005.02.006 PMID: 16112503

2005

Antibodies to neuronal structures - Innocent bystanders or neurotoxins?. DIABETES CARE. 2067-2072.

2005

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. CLINICAL THERAPEUTICS. 27:1164-1180.

Full Text via DOI: 10.1016/j.clinthera.2005.08.001 PMID: 16199243

2005

Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 73-74.

2005

Diabetic neuropathy in older adults. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 6:117-127.

2005

Are traditional risk factors for neuropathy related to poor nerve function in older adults?. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. S34-S34.

2005

Diabetic neuropathies - A statement by the American Diabetes Association. DIABETES CARE. 28:956-962.

2005

Metabolic complications of bariatric surgery: Diagnosis and management issues. GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 34:25-+.

2005

Metabolic implications of obesity: Before and after gastric bypass. GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 34:9-+.

Full Text via DOI: 10.1016/j.gtc.2004.12.009 PMID: 15823435

2005

Metabolic memory in diabetes - focus on insulin. DIABETES-METABOLISM RESEARCH AND REVIEWS. 85-90.

Full Text via DOI: 10.1002/dmrr.530 PMID: 15619272

2005

Insulin glargine improves health related quality of life in patients with type 2 diabetes inadequately controlled on sulfonylurea plus metformin. DIABETOLOGIA. A312-A312.

Researchers@EVMS

Vinik, Aaron I.
Close

Publications

selected publications

Research

principal investigator on

Contact

full name

visualizations

research areas